ERBB2 and gastric cancer: <h4>Objectives</h4>Aimed to develop and evaluate a hierarchical multimodal framework to improve HER2 status prediction in Gastric Cancer (GC) patients.<h4>Methods</h4>This retrospective study included 402 endoscopically identified GC patients (2014-2023), among whom 92 had pathologically confirmed HER2 status.